Be empowered with MS views and news. To receive The MS BEACON e-Newsletter, CLICK HERE - -
Visit our MS learning channel on YouTube, which provides hundreds of MS educational videos presented by MS Experts from across the USA. Archived here: www.youtube.com/msviewsandnews -- Also please visit our Social media platforms: Facebook, Twitter, and Instagram . Each providing important information for the MS community. Furthermore, scroll down the left side of this blog to learn from the resources and links.
Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, for your personal knowledge and to keep you informed of current health-related issues. It is not a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
Saturday, July 12, 2014
Evaluation of the Effects of Sativex (THC BDS: CBD BDS) on Inhibition of Spasticity in a Chronic Relapsing Experimental Allergic Autoimmune Encephalomyelitis: A Model of Multiple Sclerosis.
Will host an education program on August 9th in Pensacola, Florida
This will be the organizations first program in the Pan Handle since 2011 when they provided a program in Destin, Fl.
With the width of the panhandle, MS Views and News expects a nice turnout at this August 9th program.
For more detail see below
REALLY? – But You Look SO GOOD!
A Look at the Invisible Symptoms of MS
Treatment Options and Primary Symptoms that cause dysfunction in Multiple Sclerosis
Including: Memory and Bladder issues, Fatigue, Pain, Optic Dysfunction, PLUS Dietary & Self Aspects
*** RSVP Required ** see below
Brian Steingo MD – MS Neurologist, Researcher
and Medical Director of Comprehensive MS Center in Pompano, Fl.
Date: Saturday, August 9, 2014
10:50am – Registration
11:25am – Program Begins
With Complimentary Luncheon
Program Location: Crowne Plaza Pensacola
200 East Gregory Street - Pensacola, Florida 32501
RSVP online at: www.events.msvn.org
If No Internet, call Jill at: (203) 550-7703
(No Children under 16 will be permitted unless the pediatric child has Multiple Sclerosis)
Maximum of 50 people
Cognition in multiple sclerosis: Researchers publish results of one of the longest longitudinal studies
Source: Kessler Foundation
One of the longest longitudinal studies of cognition in multiple sclerosis has been completed, and its results published. These results provide insight into the natural evolution of cognitive changes over time, an important consideration for researchers and clinicians. "These longitudinal data contribute substantially to our knowledge of the course of cognitive decline in MS," noted one expert.
"While cognitive impairment is known to affect 40 to 65% of individuals with MS, few studies have followed the pattern of cognitive decline over time, which is important for understanding long-term care and outcomes associated with MS," said Dr. Strober, senior research scientist at Kessler Foundation. "Our study was based on a unique sample of 22 patients who underwent neuropsychological testing at entry into the original phase 3 clinical trial of intramuscular interferon beta-1a, and again at 18-year followup."
At baseline, 9 patients (41%) had cognitive impairment; at 18-year followup, 13 patients (59%), were found to be impaired. Significant declines over time were found in information processing speed, auditory attention, memory, episodic learning and visual construction. Decline was steeper in the unimpaired than in the impaired group, as indicated by the Symbol Digit Modalities Test (SDMT).
"These longitudinal data contribute substantially to our knowledge of the course of cognitive decline in MS," noted John DeLuca, PhD, VP of Research & Training at Kessler Foundation. "In light of the young age at diagnosis, this perspective is fundamental to the development of rehabilitation strategies that meet the needs of people dealing with the cognitive effects of MS."